4//SEC Filing
WILSON JAMES N 4
Accession 0000899243-22-022855
CIK 0001088856other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:00 PM ET
Size
13.3 KB
Accession
0000899243-22-022855
Insider Transaction Report
Form 4
WILSON JAMES N
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-14$2.08/sh+300,000$624,000→ 300,000 total - Exercise/Conversion
Stock option (right to buy)
2022-06-14+300,000→ 0 totalExercise: $2.08Exp: 2023-01-30→ Common Stock (300,000 underlying) - Other
Common Stock
2022-06-14−168,181→ 168,181 total - Other
Common Stock
2022-06-14+168,181→ 1,331,026 total(indirect: By Trust) - Tax Payment
Common Stock
2022-06-14$21.10/sh−131,819$2,781,381→ 168,181 total
Holdings
- 901,067(indirect: James and Pamela Wilson Family Partners)
Common Stock
Footnotes (4)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on June 14, 2022. The options subject to the net exercise were to expire on January 30, 2023.
- [F2]Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.
- [F3]Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F4]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001236387
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:00 PM ET
- Size
- 13.3 KB